Editorial Comment on Ischemic proctitis after low-dose-rate brachytherapy using hydrogel spacer for prostate cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35795116/
Nobumichi Tanaka is affiliated with an endowed chair funded by Nihon Medi‐Physics Co. Mariados N, Sylvester J, Shah D et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int. J. Radiat.
Conclusion: Gathering and analyzing information concerning clinical experiences of hydrogel spacer can make a suitable indication and contra-indication criteria. Also, this effort must be necessary to achieve a safety use of hydrogel spacer and avoid severe adverse events in future.